MARSHALL WACE, LLP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2023$846,443
-76.8%
80,004
-28.5%
0.00%
-90.0%
Q4 2020$3,656,000
+1524.9%
111,936
+707.9%
0.02%
+900.0%
Q2 2020$225,000
-61.1%
13,855
-63.7%
0.00%
-60.0%
Q3 2019$579,000
-91.5%
38,184
-89.0%
0.01%
-91.1%
Q2 2019$6,846,000
+820.2%
347,698
+674.7%
0.06%
+1300.0%
Q1 2019$744,000
+261.2%
44,880
+308.0%
0.00%
-55.6%
Q1 2018$206,00011,0000.01%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders